Â¥
14.73
Nov 28
New Key Statistics Module, Z-Score and F-Score
SZSE:300519 Key Ratios
Market Cap ¥ M | 2,356.80 |
Enterprise Value ¥ M | 1,648.79 |
P/E(ttm) | 54.56 |
PE Ratio without NRI | 53.76 |
Forward PE Ratio | -- |
Price/Book | 2.88 |
Price/Sales | 8.76 |
Price/Free Cash Flow | 70.84 |
Price/Owner Earnings | 67.59 |
Payout Ratio % | 1.46 |
Revenue (TTM) ¥ M | 270.00 |
EPS (TTM) ¥ | 0.27 |
Beneish M-Score | -2.26 |
10-y EBITDA Growth Rate % | -5.90 |
5-y EBITDA Growth Rate % | -3.00 |
y-y EBITDA Growth Rate % | -53.40 |
EV-to-EBIT | 49.38 |
EV-to-EBITDA | 49.38 |
PEG | -- |
Shares Outstanding M | 160.00 |
Net Margin (%) | 16.06 |
Operating Margin % | 12.34 |
Pre-tax Margin (%) | 17.27 |
Quick Ratio | 10.56 |
Current Ratio | 11.50 |
ROA % (ttm) | 4.75 |
ROE % (ttm) | 5.21 |
ROIC % (ttm) | 20.21 |
Dividend Yield % | 2.76 |
Altman Z-Score | 20.59 |
SZSE:300519 Number of Guru Trades
SZSE:300519 Volume of Guru Trades
Gurus Latest Trades with SZSE:300519
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300519 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Xinguang Pharmaceutical Co Ltd Insider Transactions
No Available Data